» Articles » PMID: 30759889

R. Verniciflua and E. Ulmoides Extract (ILF-RE) Protects Against Chronic CCl₄-Induced Liver Damage by Enhancing Antioxidation

Overview
Journal Nutrients
Date 2019 Feb 15
PMID 30759889
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to characterize the protective effects of R. verniciflua extract (ILF-R) and E. ulmoides extract (ILF-E), the combination called ILF-RE, against chronic CCl₄-induced liver oxidative injury in rats, as well as to investigate the mechanism underlying hepatoprotection by ILF-RE against CCl₄-induced hepatic dysfunction. Chronic hepatic stress was induced via intraperitoneal (IP) administration of a mixture of CCl₄ (0.2 mL/100 g body weight) and olive oil [1:1(v/v)] twice a week for 4 weeks to rats. ILF-RE was administered orally at 40, 80, and 120 mg/kg to rats for 4 weeks. Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transpeptidase (GGT), and lipid peroxidation assays were performed, and total triglyceride, cholesterol, and LDL-cholesterol levels were quantified. Furthermore, ER stress and lipogenesis-related gene expression including sterol regulatory element-binding transcription factor 1 (SREBP-1), fatty acid synthase (FAS), and P-AMPK were assessed. ILF-RE markedly protected against liver damage by inhibiting oxidative stress and increasing antioxidant enzyme activity including glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase. Furthermore, hepatic dyslipidemia was regulated after ILF-RE administration. Moreover, hepatic lipid accumulation and its associated lipogenic genes, including those encoding SREBP-1 and FAS, were regulated after ILF-RE administration. This was accompanied by regulation of ER stress response signaling, suggesting a mechanism underlying ILF-RE-mediated hepatoprotection against lipid accumulation. The present results indicate that ILF-RE exerts hepatoprotective effects against chronic CCl₄-induced dysfunction by suppressing hepatic oxidative stress and lipogenesis, suggesting that ILF-RE is a potential preventive/therapeutic natural product in treating hepatoxicity and associated dysfunction.

Citing Articles

Network pharmacology and molecular docking elucidate potential mechanisms of Eucommia ulmoides in hepatic ischemia-reperfusion injury.

Ma X, Pan B, Wang L, Feng Z, Peng C Sci Rep. 2023; 13(1):20716.

PMID: 38001230 PMC: 10673959. DOI: 10.1038/s41598-023-47918-8.


Methanolic Extract Ameliorates CCl-Induced Liver Injury by Modulating Oxidative Stress, Inflammatory, and Apoptotic Markers in Rats.

Fatima M, Khan M, Al-Keridis L, Alshammari N, Patel M, Adnan M ACS Omega. 2023; 8(29):25999-26011.

PMID: 37521626 PMC: 10373198. DOI: 10.1021/acsomega.3c02031.


IBF-R Regulates IRE1α Post-Translational Modifications and ER Stress in High-Fat Diet-Induced Obese Mice.

Lee H, Lee G, Yoon Y, Hoang T, Chae H Nutrients. 2022; 14(1).

PMID: 35011092 PMC: 8746979. DOI: 10.3390/nu14010217.


Hepatoprotective Effects of Against Carbon Tetrachloride-Induced Acute Liver Injury in Rats.

Li J, Song D, Zhang B, Guo J, Li W, Zhang X Dose Response. 2021; 19(3):15593258211029510.

PMID: 34290575 PMC: 8278464. DOI: 10.1177/15593258211029510.


Hypotensive and Hepatoprotective Properties of the Polysaccharide-Stabilized Foaming Composition Containing Hydrolysate of Whey Proteins.

Kruchinin A, Savinova O, Glazunova O, Moiseenko K, Agarkova E, Fedorova T Nutrients. 2021; 13(3).

PMID: 33806781 PMC: 8004872. DOI: 10.3390/nu13031031.


References
1.
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M . Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999; 26(9-10):1231-7. DOI: 10.1016/s0891-5849(98)00315-3. View

2.
Deyama T, Nishibe S, Nakazawa Y . Constituents and pharmacological effects of Eucommia and Siberian ginseng. Acta Pharmacol Sin. 2001; 22(12):1057-70. View

3.
BLIGH E, Dyer W . A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959; 37(8):911-7. DOI: 10.1139/o59-099. View

4.
Rees K, SPECTOR W . Reversible nature of liver cell damage due to carbon tetrachloride as demonstrated by the use of phenergan. Nature. 1961; 190:821-2. DOI: 10.1038/190821a0. View

5.
Yang Y, Cao J, Shi Y . Identification and characterization of a gene encoding human LPGAT1, an endoplasmic reticulum-associated lysophosphatidylglycerol acyltransferase. J Biol Chem. 2004; 279(53):55866-74. DOI: 10.1074/jbc.M406710200. View